Parameters of intracardiac hemodynamics in iron deficiency in patients with chronic heart failure

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Iron deficiency is a common comorbidity in many patients with chronic heart failure.

AIM: To study the parameters of intracardiac hemodynamics in the patients with chronic heart failure in the presence of iron deficiency.

MATERIALS AND METHODS: We examined 179 patients (36 men and 143 women, mean age 71.6 ± 7.9 years) with heart failure of functional class 2-4 (NYHA). All the patients underwent a clinical examination, a 6-minute walk test, a general blood test; the level of NT-proBNP, iron, transferrin, and ferritin in blood serum were studied; the percentage of transferrin saturation with iron was calculated. The presence of iron deficiency was assessed based on a decrease in the level of serum ferritin less than 100 μg/L or ferritin ranging from 100 to 299 μg/L and saturation of transferrin with iron less than 20%. All the patients underwent echocardiography in one-dimensional, two-dimensional and Doppler modes (pulse-wave, constant-wave and tissue) in standard positions according to the generally accepted technique.

RESULTS: It was found that in the patients with chronic heart failure and iron deficiency compared with the patients without iron deficiency; the end systolic volume of the left ventricle, the size of the right ventricle and the systolic pressure in the pulmonary artery were significantly higher, and the speed of movement of the fibrous ring of the mitral and tricuspid valves and the working capacity were lower. Significant correlations were established between the concentration of iron and ferritin and the parameters of intracardiac hemodynamics.

CONCLUSIONS: Iron deficiency in the patients with chronic heart failure without anemia contributes to an early initial decrease in cardiac contractility with an intact ejection fraction.

Full Text

Restricted Access

About the authors

Marina P. Smirnova

Yaroslavl State Medical University

Author for correspondence.
Email: msm76-743@yandex.ru
ORCID iD: 0000-0002-8988-998X
SPIN-code: 4399-0900

MD, Cand. Sci. (Med.), Assistant Professor

Russian Federation, 5 Revolyutsionnaya str., Yaroslavl, 150000

Petr A. Chizhov

Yaroslavl State Medical University

Email: p.chizhov63@gmail.com
ORCID iD: 0000-0001-7969-6538
SPIN-code: 6427-4298

MD, Dr. Sci. (Med.), Professor

Russian Federation, 5 Revolyutsionnaya str., Yaroslavl, 150000

Andrey A. Baranov

Yaroslavl State Medical University

Email: bara_aa@mail.ru
ORCID iD: 0000-0001-7847-1679
SPIN-code: 4497-7008

MD, Dr. Sci. (Med.), Professor

Russian Federation, 5 Revolyutsionnaya str., Yaroslavl, 150000

Yuliya I. Ivanova

Yaroslavl State Medical University

Email: yuliaivanova48@yandex.ru
ORCID iD: 0000-0001-6349-4587
SPIN-code: 5884-0367

MD, Cand. Sci. (Med.), Assistant Professor

Russian Federation, 5 Revolyutsionnaya str., Yaroslavl, 150000

References

  1. Peyrin-Biroulet L,Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585–1594. doi: 10.3945/ajcn.114.103366
  2. Smirnova MP, Chizhov PA, Baranov AA. Anemia and ferrum deficiency in patients with heart failure. Bulletin of the Ivanovo state medical academy. 2018;23(1):12–16. (In Russ.)
  3. Jankowska EA, Tkaczyszyn M, Drozd M, Ponikowski P. Monitoring of iron status in patients with heart failure. Eur Heart J Suppl. 2019;21(Suppl M):M32–M35. doi: 10.1093/eurheartj/suz231
  4. Tkaczyszyn M, Drozd M, Ponikowski P, Jankowska EA. Iron deficiency in heart failure: a 2020 update. Kardiol Pol. 2019;77(12):1134–1139. doi: 10.33963/KP.15089
  5. Maeder MT, Khammy O, Remrdios C, Kaye DM. Myocardial and systemic iron depletion in heart failure: implicatins for anemia accompanying heart failure. J Am Coll Cardiol. 2011;58(5):474–480. DOI: 10/1016/j.jacc.2011.01.059
  6. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657–668. doi: 10.1093/eurheartj/ehu385
  7. Jankowska EA, Tkaczyszyn M, Suchocki T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016;18(7):786–795. doi: 10.1002/ejhf.473
  8. Anker SD, Kirwan BA, van Veldhuisen DJ, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20(1):125–133. doi: 10.1002/ejhf.823
  9. Galy B, Ferring-Appel D, Sauer SW, et al. Iron regulatory proteins secure mitochondrial iron sufficiency and function. Cell Metab. 2010;12(2):194–201. doi: 10.1016/j.cmet.2010.06.007
  10. Hower V, Mendes P, Torti FM, et al. A general map of iron metabolism and tissue-specific subnetworks. Mol Biosyst. 2009;5(5):422–443. doi: 10.1039/b816714c
  11. Mareev VYu, Ageev FT, Arutyunov GP, et al. National guidelines for diagnosis and treatment of chronic heart failure (4th review). Russian Heart Failure Journal. 2013;14(7(81)):379–472. (In Russ.)
  12. Iron deficiency anemia. Assessment, prevention and control. A guide for program managers. Geneva: World Health Organization; 2008.
  13. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18 (8): 891–975. doi: 10.1002/ejhf.592
  14. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. doi: 10.1016/j.echo2016.01.011
  15. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. doi: 10.1016/j.echo.2014.10.003
  16. Morris DA, Boldt LH, Eichstäd H, et al. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction. Circ Heart Fail. 2012;5(5):610–620. doi: 10.1161/CIRCHEARTFAILURE.112.966564
  17. Phan TT, Shivu GN, Abozguia K, et al. Left ventricular torsion and strain patterns in heart failure with normal ejection fraction are similar to age-related changes. Eur J Echocardiogr. 2009;10(6):793–800. doi: 10.1093/ejechocard/jep072
  18. Wang J, Khoury DS, Yue Y. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J. 2008;29(10):1283–1289. doi: 10.1093/eurheartj/ehn141
  19. Martens P, Nijst P, Verbrugge FH, et al. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, midrange and preserved ejection fraction. Acta Cardiol. 2018;73(2):115–123. doi: 10.1080/0015385.2017/1351239
  20. Belmar VL, De Francisco A, Albines FZ, et al. Investigation of iron deficiency in patients with congestive heart failure: a medical practice that requires greater attention. Nefrologia. 2016;36(3):249–254. doi: 10.1016/j.nefro.2016.03.001
  21. Van Veldhuisen DJ, Ponikowski P, van der Meer P, et al. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017;136(15):1374–1383. doi: 10.1161/CIRCULATIONAHA.117.027497

Supplementary files

There are no supplementary files to display.

Statistics

Views

Abstract: 149

PDF (Russian): 1

Dimensions

Article Metrics

Metrics Loading ...

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2021 Smirnova M.P., Chizhov P.A., Baranov A.A., Ivanova Y.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies